This study employs a comprehensive bioinformatics approach to investigate the role of CPLX1 as a novel prognostic biomarker in colorectal cancer (CRC), particularly in relation to immunotherapy resistance and ferroptosis. The gene discussed is CPLX1; the disease is colorectal cancer.